PharmaVOICE Podcasts

PharmaVOICE Podcasts

By Daniel LimbachMedicine
Download on the App Store

PharmaVOICE Podcasts episodes

  • Automating Pharma FCPA Due Diligence
    Thought Leader: Robert Shecterle, Vice President of Marketing, Aravo In this episode, Mr. Shecterle discusses FCPA Compliance and anti-bribery practices at large pharmaceutical and life sciences companies. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
    0 min
  • Transformative Leadership
    Thought Leader: Dr. Deborah Dunsire, President and CEO, Millennium: The Takeda Oncology Company In this episode, Dr. Dunsire shares her insights on the quest to find a cure for cancer, on women striving for positions in the C-Suite, and thoughts on her own career development and recognition as the 2009 HBA Woman of the Year. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
    0 min
  • How the New Role of the CRO Affects Patient Enrollment
    Thought Leader: Richard Malcolm, CEO, Acurian In this episode, Dr. Malcolm discusses how the role of the CRO is transitioning from commodity service supplier to strategic partner, and the unintended negative consequences this could have on what is already the most expensive part of clinical trials: patient enrollment. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
    0 min
  • The Evolving Social Media Lifecycle in Pharma
    Thought Leaders: Nagaraja Srivatsan, Dileep Srinivasan, and Alexander Gochtovtt, Cognizant In this episode, a trio of experts from Cognizant talk about numerous issues involving social media in the life sciences. There is also a related white paper you may download. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
    0 min
  • Understanding the Impact of Drug Induced Liver Injury on Drug Development
    Thought Leader: Steve Lobel, PhD, D-ABMLI, MBA, FACB, Vice-president Global Laboratory Operations, PPD In this episode, Dr. Lobel talks about Drug-induced liver injury, also known as DILI. We'll cover what DILI is, how it is identified, and its effects on the clinical development process. At the end of this podcast, you'll learn where you can download a related white paper on this topic. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
    0 min
  • DIA 2012 48th Annual Meeting Preview
    Thought Leader: Craig Lipset, DIA Conference Chair, Head of Clinical Innovation, Development Operations within Worldwide Research & Development, Pfizer In this episode of the PharmaVOICE Executive Suite Podcast Series, Mr. Lipset shares his thoughts on being Chairman of the DIA 2012 48th Annual Meeting in June, and how his work at Pfizer helps him in his role with DIA including this year's theme on collaboration. He also comments on how industry trends will impact drug development and clinical trials, and offers a couple tips on getting the most out of this year's DIA Annual Meeting in Philadelphia. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
    0 min
  • Patient Access to Investigational Drugs: Removing Barriers
    Thought Leader: Simon Estcourt, Senior VP, Strategy and Corporate Development, Idis In this episode, Mr. Estcourt shares his perspective on programs that enable patient access to medicines outside the clinical trial or commercial setting and the barriers that remain despite well-defined regulations governing such access. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
    0 min
  • Top Ten Patient Enrollment and Retention Myths
    Thought Leader: Scott Connor, VP of Marketing, Acurian In this episode, Mr. Connor shares 4 of his top 10 myths about patient enrollment and retention, and we'll tell you where to get the entire list. For more information about Acurian, visit www.acurian.com. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
    0 min
  • Improve Adherence with Patient and Caregiver Support Programs
    Thought Leader: Lou Shapiro, Senior VP, Business Development, Tunstall AMAC Life Sciences In this episode, Mr. Shapiro discusses why patient support programs are valuable, how to start a program, the necessity for delivering personalized information, several critical success factors for a program, and understanding health care from the patient's perspective. For more information about Tunstall AMAC Life Sciences, visit www.phonescreen.com. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
    0 min
  • Insights from the Field: Tele-Sales Builds Relationships between Brand and HCPs
    Thought Leader: Lou Shapiro, Senior VP, Business Development, PhoneScreen, an AMAC company In this episode, Mr. Shapiro describes his experiences working with companies on successful tele-detailing and tele-sales programs, including numerous insights on the unforeseen benefits of these solutions. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
    16 min

About PharmaVOICE Podcasts

From the publisher's feed

PharmaVOICE interviews movers and shakers from the life sciences. We'll bring you interviews with executives from pharma and biotech as well as service providers to give you interesting stories from…